We Need More Randomized Clinical Trials of AI
NEJM AI · 24.10.2024 · 1 (11)
DOI: 10.1056/aie2400881 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM AI, erschienen am 24.10.2024. Verfasst von David Ouyang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
AbstractIn the first prospective clinical trial of artificial intelligence (AI) assistance in stress echocardiography, there was no difference in diagnostic accuracy between AI assistance and standard-of-care assessment. There is significant value in conducting prospective clinical trials of AI, and there are lessons on implementation to be learned from this study.
Autor:innen und Institutionen
- Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles.
- Department of Biostatistics, Brown University School of Public Health, Providence, RI.
ORCID-Profile: David Ouyang, Joseph Hogan
Zitieren
APA
Ouyang, D., & Hogan, J. (2024). We Need More Randomized Clinical Trials of AI. NEJM AI, 1(11). https://doi.org/10.1056/aie2400881
Vancouver
Ouyang D, Hogan J. We Need More Randomized Clinical Trials of AI. NEJM AI. 2024;1(11). doi:10.1056/aie2400881
BibTeX
@article{Ouyang2024,
author = {Ouyang, David and Hogan, Joseph},
title = {We Need More Randomized Clinical Trials of AI},
journal = {NEJM AI},
year = {2024},
volume = {1},
number = {11},
doi = {10.1056/aie2400881}
}
EUVIMED